Botulinum Neurotoxin Type A: Clinical Trials

7 trials of Botulinum Neurotoxin Type A, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 2 unknown, 1 recruiting. 7 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 2, Terminated 2, Unknown 2, Recruiting 1
Phase 11Unknown 1

Follow Botulinum Neurotoxin Type A: new trials by email Literature Review of Botulinum Neurotoxin Type A trials Research Report on Botulinum Neurotoxin Type A

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
DaxibotulinumtoxinA for Blepharospasm
Botulinum Neurotoxin Type A - Blepharospasm of Both Eyelids, Blepharospasm of Left Eyelid
Phase 2RecruitingUniversity of Pennsylvania202026-09-242026-09-29
Study of the Drug B11-FC (Botulism Treatment)
B11-FC, Botulinum neurotoxin type A, Placebo - Botulism
Phase 1 / Phase 2UnknownGamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation402024-08-012024-08-30
Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy
Botulinum Toxin Type A - Pancreatic Carcinoma
Phase 2TerminatedOHSU Knight Cancer Institute42023-03-012025-05-13
Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer
Botulinum Toxin Type A, Esophagectomy, Quality-of-Life Assessment - Esophageal Carcinoma
Phase 2CompletedRoswell Park Cancer Institute332016-12-302023-02-16
Botulinum Toxin in Burning Mouth Syndrome
Botulinum Neurotoxin Type A, Normal saline - Burning Mouth Syndrome
Phase 2CompletedPresidio Ospedaliero Garibaldi-Centro62015-11-012016-12-07
Kinematic-guided BoNT-A Treatment for ET and PD Tremor
BoNT-A - Tremor
Phase 2UnknownWestern University, Canada542011-10-012019-08-20
Safety and Efficacy of the Use of Botox on Acne
Botulinum Neurotoxin Type A, Bacteriostatic saline - Acne Vulgaris
Phase 2TerminatedDeNova Research52008-09-012018-06-29

Conditions studied

Acne Vulgaris (1)  ·  Benign essential blepharospasm (1)  ·  Blepharospasm (1)  ·  Botulism (1)  ·  Burning Mouth Syndrome (1)  ·  Dystonia (1)  ·  Esophageal Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Parkinsonian Disorders (1)  ·  Tremor (1)

Sponsors

DeNova Research (1)  ·  Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation (1)  ·  OHSU Knight Cancer Institute (1)  ·  Presidio Ospedaliero Garibaldi-Centro (1)  ·  Roswell Park Cancer Institute (1)  ·  University of Pennsylvania (1)  ·  Western University, Canada (1)

Countries

United States (4)

Top investigators

Brett C Sheppard, M.D., FACS (1)  ·  Mandar Jog, MD, FRCPC (1)  ·  Moshim Kukar (1)  ·  Steven H Dayan, MD F.A.C.S. (1)

Results publications

PMID 12963779, PMID 15911160, PMID 18546285, PMID 27101283